Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM, Thompson A, Toly C (2021) 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 143:e35-71
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, Capodanno D, Conradi L, De Bonis M, De Paulis R, Delgado V, Freemantle N, Gilard M, Haugaa KH, Jeppsson A, Jüni P, Pierard L, Prendergast BD, Sádaba JR, Tribouilloy C, Wojakowski W, ESC/EACTS Scientific Document Group, ESC National Cardiac Societies (2022) 2021 ESC/EACTS guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 43:561–632
Sá MP, Erten O, Ramlawi B (2022) Transcatheter aortic valve implantation in elderly patients with aortic valve stenosis: the role of frailty, malnutrition, and sarcopenia. J Am Heart Assoc 11:e027705
Article PubMed PubMed Central Google Scholar
Regev E, Finkelstein A, Assali A, Barbash I, Fefer P, Ben-Shoshan J, Orvin K, Konigstein M, Guetta V, Kornowski R, Segev A (2017) Comparison of outcome of transcatheter aortic valve implantation for severe aortic stenosis in 3 age groups (≤70; 71 to 80, and ≥81 years). Am J Cardiol 120:1607–1611
Grundmann D, Linder M, Goßling A, Voigtländer L, Ludwig S, Waldschmidt L, Demal T, Bhadra OD, Schäfer A, Schirmer J, Reichenspurner H, Blankenberg S, Westermann D, Schofer N, Conradi L, Seiffert M (2022) End-stage renal disease, calcification patterns and clinical outcomes after TAVI. Clin Res Cardiol 111:1313–1324
Levi A, Codner P, Masalha A, Gargiulo G, Praz F, Hayashida K, Watanabe Y, Mylotte D, Debry N, Barbanti M, Lefèvre T, Modine T, Bosmans J, Windecker S, Barbash I, Sinning J-M, Nickenig G, Barsheshet A, Kornowski R (2017) Predictors of 1-year mortality after transcatheter aortic valve implantation in patients with and without advanced chronic kidney disease. Am J Cardiol 120:2025–2030
Schoechlin S, Eichenlaub M, Müller-Edenborn B, Neumann F-J, Arentz T, Westermann D, Jadidi A (2022) Risk stratification for pacemaker implantation after transcatheter aortic valve implantation in patients with right bundle branch block. J Clin Med 11:5580
Article PubMed PubMed Central Google Scholar
Schaefer A, Neumann N, Linder M, Schofer N, Schneeberger Y, Deuschl F, Schoen G, Blankenberg S, Reichenspurner H, Conradi L, Schäfer U (2018) Outcomes with a latest generation self-expandable, intra-annular, re-sheathable transcatheter heart valve system: analysis of patients with impaired left ventricular function and determinants for pacemaker implantation. Clin Res Cardiol 107:914–923
Wienemann H, Maier O, Beyer M, Portratz M, Tanaka T, Mauri V, Ernst A, Waldschmidt L, Kuhn E, Bleiziffer S, Wilde N, Schaefer A, Zeus T, Baldus S, Zimmer S, Veulemans V, Rudolph TK, Adam M (2023) Cusp overlap versus standard three-cusp technique for self-expanding Evolut transcatheter aortic valves. EuroIntervention 19(2):e176–e187. https://doi.org/10.4244/EIJ-D-22-01030
Veulemans V, Nuyens P, Goh S, Maier O, Binnebößel S, Heermann J, Jung C, Westenfeld R, Kelm M, de Backer O, Zeus T (2022) Bioprosthetic valve dysfunction and failure after TAVI in bicuspid aortic valve stenosis during one-year follow-up according to VARC-3. Clin Res Cardiol 111:1358–1366
Article PubMed PubMed Central Google Scholar
Kiefer NJ, Salber GC, Burke GM, Chang JD, Guibone KA, Popma JJ, Hahn RT, Pinto DS, Strom JB (2019) The impact of basal septal hypertrophy on outcomes after transcatheter aortic valve replacement. J Am Soc Echocardiogr 32:1416–1425
Article PubMed PubMed Central Google Scholar
Shapiro LM, Howat AP, Crean PA, Westgate CJ (1986) An echocardiographic study of localized subaortic hypertrophy. Eur Heart J 7:127–132
Article CAS PubMed Google Scholar
Kelshiker MA, Mayet J, Unsworth B, Okonko DO (2013) Basal septal hypertrophy. Curr Cardiol Rev 9:316–324
Moreno R, Calvo L, García E, Dobarro D (2010) Severe septal hypertrophy: is it necessarily a contraindication for the transcatheter implantation of an Edwards-Sapien prosthesis? Rev Esp Cardiol 63:241–242
Diaz T, Pencina MJ, Benjamin EJ, Aragam J, Fuller DL, Pencina KM, Levy D, Vasan RS (2009) Prevalence, clinical correlates and prognosis of discrete upper septal thickening on echocardiography. Echocardiography 26:247–253
Bandyopadhyay D, Chakraborty S, Amgai B, Kapadia SR, Braunwald E, Naidu SS, Kalra A (2020) Association of hypertrophic obstructive cardiomyopathy with outcomes following transcatheter aortic valve replacement. JAMA Netw Open 3:e1921669
Article PubMed PubMed Central Google Scholar
VARC-3 WRITING COMMITTEE, Généreux P, Piazza N, Alu MC, Nazif T, Hahn RT, Pibarot P, Bax JJ, Leipsic JA, Blanke P, Blackstone EH, Finn MT, Kapadia S, Linke A, Mack MJ, Makkar R, Mehran R, Popma JJ, Reardon M, Rodes-Cabau J, Van Mieghem NM, Webb JG, Cohen DJ, Leon MB (2021) Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol 77:2717–46
Maron BJ, Clark CE, Henry WL, Fukuda T, Edwards JE, Mathews EC, Redwood DR, Epstein SE (1977) Prevalence and characteristics of disproportionate ventricular septal thickening in patients with acquired or congenital heart diseases: echocardiographic and morphologic findings. Circulation 55:489–496
Article CAS PubMed Google Scholar
Hess OM, Schneider J, Turina M, Carroll JD, Rothlin M, Krayenbuehl HP (1983) Asymmetric septal hypertrophy in patients with aortic stenosis: an adaptive mechanism or a coexistence of hypertrophic cardiomyopathy. J Am Coll Cardiol 1:783–789
Article CAS PubMed Google Scholar
Krishnaswamy A, Tuzcu EM, Svensson LG, Kapadia SR (2013) Combined transcatheter aortic valve replacement and emergent alcohol septal ablation. Circulation 128:e366–e368
Bird JJ, Murgo JP, Pasipoularides A (1982) Fluid dynamics of aortic stenosis: subvalvular gradients without subvalvular obstruction. Circulation 66:835–840
Article CAS PubMed Google Scholar
Pascual I, Hernández-Vaquero D, Alperi A, Almendarez M, Avanzas P, Kalavrouziotis D, Lorca R, Mesnier J, Arboine L, Mohammadi S, Valle RD, Dumont E, Leon V, De Larochelliere R, Rodés-Cabau J, Moris C (2022) Permanent pacemaker reduction using cusp-overlapping projection in TAVR: a propensity score analysis. JACC Cardiovasc Interv 15:150–161
Sammour Y, Banerjee K, Kumar A, Lak H, Chawla S, Incognito C, Patel J, Kaur M, Abdelfattah O, Svensson LG, Tuzcu EM, Reed GW, Puri R, Yun J, Krishnaswamy A, Kapadia S (2021) Systematic approach to high implantation of SAPIEN-3 valve achieves a lower rate of conduction abnormalities including pacemaker implantation. Circ: Cardiovasc Interv 14(1):e009407. https://doi.org/10.1161/CIRCINTERVENTIONS.120.009407
Khan AA, Tang GHL, Engstrom K, Khan M, Patel N, Dangas GD, Sharma SK, Kini A (2019) Aortic stenosis with severe asymmetric septal hypertrophy: a novel management strategy to improve TAVR outcomes. JACC: Cardiovasc Interv 12:2228–2230. https://doi.org/10.1016/j.jcin.2019.06.025
Qintar M, Villablanca P, Lee J, Wang DD, Frisoli T, O’Neill B, Eng MH, O’Neill WW (2021) Emergency alcohol septal ablation for shock after TAVR: one more option in the toolbox. JACC Case Rep 3:853–858
Article PubMed PubMed Central Google Scholar
Kotkar KD, Said SM, Dearani JA, Schaff HV (2017) Hypertrophic obstructive cardiomyopathy: the Mayo Clinic experience. Ann Cardiothorac Surg 6:32936–32336
留言 (0)